Adenoviruses (Ad) contain genes that appear dedicated to the control of the host immune and cytokine responses in such a way as to facilitate either the efficiency of acute infection or the persistence of the virus. Many of these genes are clustered in early region 3 (E3), which codes for a gp19kDa protein that inhibits transport of the class I major histocompatibility complex (MHC) to the plasma membrane, a 14.7 kDa protein that inhibits tumor necrosis factor alpha (TNFa) cytolysis and a heterotrimeric complex of 2 polypeptides (10.4kDa and 14.5 kDa) that also inhibit the action of TNFa. The applicant postulated that the E3 genes, expressed under the control of a strong promoter, might downregulate the immune response to Ad-based, gene-therapy vectors and promote long term expression of Ad-delivered therapeutic genes. Recent experiments from our lab have proven that this postulate was correct. Remarkably, the overexpression of Ad E3 genes not only inhibited class I based cytotoxic T lymphocyte (CTL) responses but also profoundly inhibited the formation of neutralizing antibodies to the virus. This surprising observation has lead the applicant to a series of questions that ask (a) which of the Ad E3 genes are responsible for the abrogation of the antibody response, (b) whether the Ad E3 gene(s) can control the immune response to foreign proteins, synthesized and secreted from the liver and (c) how the E3 genes could be delivered and function in hepatocytes to facilitate allogeneic hepatocyte transplantation.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI042295-02
Application #
2887649
Study Section
Experimental Virology Study Section (EVR)
Program Officer
Beisel, Christopher E
Project Start
1998-07-01
Project End
2003-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Shifera, Amde Selassie; Horwitz, Marshall S (2008) Mutations in the zinc finger domain of IKK gamma block the activation of NF-kappa B and the induction of IL-2 in stimulated T lymphocytes. Mol Immunol 45:1633-45
Shifera, Amde Selassie; Friedman, Joshua M; Horwitz, Marshall S (2008) IKK gamma (NEMO) is involved in the coordination of the AP-1 and NF-kappa B pathways. Mol Cell Biochem 310:181-90
Horwitz, Marshall S (2004) Function of adenovirus E3 proteins and their interactions with immunoregulatory cell proteins. J Gene Med 6 Suppl 1:S172-83
Wadler, Scott; Yu, Bo; Tan, Jian-You et al. (2003) Persistent replication of the modified chimeric adenovirus ONYX-015 in both tumor and stromal cells from a patient with gall bladder carcinoma implants. Clin Cancer Res 9:33-43
Guha, Chandan; Shah, Shalin J; Ghosh, Siddhartha S et al. (2003) Molecular therapies for viral hepatitis. BioDrugs 17:81-91
Lesokhin, Alexander M; Delgado-Lopez, Fernando; Horwitz, Marshall S (2002) Inhibition of chemokine expression by adenovirus early region three (E3) genes. J Virol 76:8236-43
Friedman, Joshua M; Horwitz, Marshall S (2002) Inhibition of tumor necrosis factor alpha-induced NF-kappa B activation by the adenovirus E3-10.4/14.5K complex. J Virol 76:5515-21
Reddy, B; Gupta, S; Chuzhin, Y et al. (2001) The effect of CD28/B7 blockade on alloreactive T and B cells after liver cell transplantation. Transplantation 71:801-11
Horwitz, M S (2001) Adenovirus immunoregulatory genes and their cellular targets. Virology 279:1-8